Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1970 Jun 20;102(13):1379–1383.

Platelet function: a review. II. Abnormal function.

S Berger
PMCID: PMC1930302  PMID: 4912295

Full text

PDF
1379

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AAS K. A., GARDNER F. H. Survival of blood platelets labeled with chromium. J Clin Invest. 1958 Sep;37(9):1257–1268. doi: 10.1172/JCI103713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ABRAHAMSEN A. F. THE EFFECT OF EDTA AND ACD ON THE RECOVERY AND SURVIVAL OF CR51-LABELLED BLOOD PLATELETS. Scand J Haematol. 1965;2:52–60. doi: 10.1111/j.1600-0609.1965.tb01278.x. [DOI] [PubMed] [Google Scholar]
  3. ASTER R. H., JANDL J. H. PLATELET SEQUESTRATION IN MAN. I. METHODS. J Clin Invest. 1964 May;43:843–855. doi: 10.1172/JCI104970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Anthony M., Hinterberger H., Lance J. W. Plasma serotonin in migraine and stress. Arch Neurol. 1967 May;16(5):544–552. doi: 10.1001/archneur.1967.00470230096013. [DOI] [PubMed] [Google Scholar]
  5. BETTEX-GALLAND M., LUSCHER E. F. Studies on the metabolism of human blood platelets in relation to clot retraction. Thromb Diath Haemorrh. 1960 Mar 1;4:178–195. [PubMed] [Google Scholar]
  6. BONNIN J. A. Studies of platelet function as a guide to the severity of thrombocytopenic purpura and the possible mechanism of purpura and haemorrhage. Australas Ann Med. 1957 Aug;6(3):196–202. doi: 10.1111/imj.1957.6.3.196. [DOI] [PubMed] [Google Scholar]
  7. BORN G. V. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962 Jun 9;194:927–929. doi: 10.1038/194927b0. [DOI] [PubMed] [Google Scholar]
  8. BORN G. V., GILLSON R. E. Studies on the uptake of 5-hydroxytryptamine by blood platelets. J Physiol. 1959 Jun 11;146(3):472–491. doi: 10.1113/jphysiol.1959.sp006206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. BOWIE E. J., THOMPSON J. H., Jr, OWEN C. A., Jr THE BLOOD PLATELET (INCLUDING A DISCUSSION OF THE QUALITATIVE PLATELET DISEASES). Mayo Clin Proc. 1965 Aug;40:625–651. [PubMed] [Google Scholar]
  10. Behnke O. An electron microscope study of the megacaryocyte of the rat bone marrow. I. The development of the demarcation membrane system and the platelet surface coat. J Ultrastruct Res. 1968 Sep;24(5):412–433. doi: 10.1016/s0022-5320(68)80046-2. [DOI] [PubMed] [Google Scholar]
  11. Behnke O. Electron microscopic observations on the membrane systems of the rat blood platelet. Anat Rec. 1967 Jun;158(2):121–137. doi: 10.1002/ar.1091580203. [DOI] [PubMed] [Google Scholar]
  12. Behnke O. Electron microscopical observations on the surface coating of human blood platelets. J Ultrastruct Res. 1968 Jul;24(1):51–69. doi: 10.1016/s0022-5320(68)80016-4. [DOI] [PubMed] [Google Scholar]
  13. Bermingham M. A., Boggust W. A., O'Meara R. A. Lipids and phospholipids in blood coagulation. Nature. 1968 May 18;218(5142):695–696. doi: 10.1038/218695a0. [DOI] [PubMed] [Google Scholar]
  14. Bolton C. H., Hampton J. R., Mitchell J. R. Effect of oral contraceptive agents on platelets and plasma-phospholipids. Lancet. 1968 Jun 22;1(7556):1336–1341. doi: 10.1016/s0140-6736(68)92036-9. [DOI] [PubMed] [Google Scholar]
  15. Booyse F. M., Rafelson M. E., Jr Studies on human platelets. 3. A contractile protein model for platelet aggregation. Blood. 1969 Jan;33(1):100–103. [PubMed] [Google Scholar]
  16. Bowie E. J., Owen C. A., Jr Purpura: diagnostic possibilities. Postgrad Med. 1968 May;43(5):104–109. doi: 10.1080/00325481.1968.11693249. [DOI] [PubMed] [Google Scholar]
  17. CASTALDI P. A., FIRKIN B. G. STUDIES OF THE LIFE SPAN AND FATE OF PLATELETS. Australas Ann Med. 1963 Nov;12:333–341. doi: 10.1111/imj.1963.12.4.333. [DOI] [PubMed] [Google Scholar]
  18. CETINGIL A. I., ULUTIN O. N., KARACA M. A platelet defect in a case of scurvy. Br J Haematol. 1958 Jul;4(3):350–354. doi: 10.1111/j.1365-2141.1958.tb06037.x. [DOI] [PubMed] [Google Scholar]
  19. CHENEY K., BONNIN J. A. Haemorrhage, platelet dysfunction and other coagulation defects in uraemia. Br J Haematol. 1962 Jul;8:215–222. doi: 10.1111/j.1365-2141.1962.tb06514.x. [DOI] [PubMed] [Google Scholar]
  20. COHEN P., GARDNER F. H., BARNETT G. O. Reclassification of the thrombocytopenias by the Cr51-labeling method for measuring platelet life span. N Engl J Med. 1961 Jun 22;264:1294–contd. doi: 10.1056/NEJM196106222642506. [DOI] [PubMed] [Google Scholar]
  21. COHEN P., GARDNER F. H., BARNETT G. O. Reclassification of the thrombocytopenias by the Cr51-labeling method for measuring platelet life span. N Engl J Med. 1961 Jun 29;264:1350–concl. doi: 10.1056/NEJM196106292642607. [DOI] [PubMed] [Google Scholar]
  22. CROSBY W. H. Paroxysmal nocturnal hemoglobinuria; plasma factors of the hemolytic system. Blood. 1953 May;8(5):444–458. [PubMed] [Google Scholar]
  23. Castaldi P. A., Caen J. Platelet fibrinogen. J Clin Pathol. 1965 Sep;18(5):579–585. doi: 10.1136/jcp.18.5.579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Curran D. A., Hinterberger H., Lance J. W. Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects. Brain. 1965 Dec;88(5):997–1010. doi: 10.1093/brain/88.5.997. [DOI] [PubMed] [Google Scholar]
  25. DAVEY M. G., LANDER H. THE BEHAVIOUR OF INFUSED HUMAN PLATELETS DURING THE FIRST TWENTY-FOUR HOURS AFTER INFUSION. Br J Haematol. 1964 Jan;10:94–109. doi: 10.1111/j.1365-2141.1964.tb00682.x. [DOI] [PubMed] [Google Scholar]
  26. De Jongh D. S., Shively J. A. Methods of evaluating platelet survival. Tex Rep Biol Med. 1968 Summer;26(2):181–188. [PubMed] [Google Scholar]
  27. Didisheim P., Bunting D. Abnormal platelet function in myelofibrosis. Am J Clin Pathol. 1966 May;45(5):566–573. doi: 10.1093/ajcp/45.5.566. [DOI] [PubMed] [Google Scholar]
  28. Elkeles R. S., Hampton J. R., Mitchell J. R. Effect of oestrogens on human platelet behaviour. Lancet. 1968 Aug 10;2(7563):315–318. doi: 10.1016/s0140-6736(68)90528-x. [DOI] [PubMed] [Google Scholar]
  29. Emmons P. R., Harrison M. J., Honour A. J., Mitchell J. R. Effect of dipyridamole on human platelet behaviour. Lancet. 1965 Sep 25;2(7413):603–606. doi: 10.1016/s0140-6736(65)90515-5. [DOI] [PubMed] [Google Scholar]
  30. Evans G., Mustard J. F. Platelet-surface reaction and thrombosis. Surgery. 1968 Jul;64(1):273–280. [PubMed] [Google Scholar]
  31. Evans G., Packham M. A., Nishizawa E. E., Mustard J. F., Murphy E. A. The effect of acetylsalicyclic acid on platelet function. J Exp Med. 1968 Nov 1;128(5):877–894. doi: 10.1084/jem.128.5.877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. GAARDER A., LALAND S. HYPOTHESIS FOR THE AGGREGATION OF PLATELETS BY NUCLEOTIDES. Nature. 1964 May 30;202:909–910. doi: 10.1038/202909a0. [DOI] [PubMed] [Google Scholar]
  33. GODAL H. C. A study on the beta naphtol reaction of plasma ("fibrinogen B"-test). Scand J Clin Lab Invest. 1962;14:203–206. doi: 10.3109/00365516209079694. [DOI] [PubMed] [Google Scholar]
  34. GUNZ F. W. Hemorrhagic thrombocythemia: a critical review. Blood. 1960 May;15:706–723. [PubMed] [Google Scholar]
  35. Gray G. R., Wilson P. A., Douglas A. S. The effect on dipyridamole on platelet aggregation and adhesiveness. Scott Med J. 1968 Dec;13(12):409–415. doi: 10.1177/003693306801301202. [DOI] [PubMed] [Google Scholar]
  36. HELLEM A., OWREN P. A. THE MECHANISM OF THE HEMOSTATIC FUNCTION OF BLOOD PLATELETS. Acta Haematol. 1964 Apr;31:230–238. doi: 10.1159/000209632. [DOI] [PubMed] [Google Scholar]
  37. HJORT P., RAPAPORT S. I., OWREN P. A. Evidence that platelet accelerator (platelet factor 1) is adsorbed plasma proaccelerin. Blood. 1955 Nov;10(11):1139–1150. [PubMed] [Google Scholar]
  38. HOLEMANS R., GROSS R. Influence of blood platelets on fibrinolysis. Thromb Diath Haemorrh. 1961 Sep 1;6:196–214. [PubMed] [Google Scholar]
  39. Hampton J. R., Mitchell J. R. Effect of glass contact on the electrophoretic mobility of human blood platelets. Nature. 1966 Jan 29;209(5022):470–472. doi: 10.1038/209470a0. [DOI] [PubMed] [Google Scholar]
  40. Harker L. A. Kinetics of thrombopoiesis. J Clin Invest. 1968 Mar;47(3):458–465. doi: 10.1172/JCI105742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Hemker H. C., Esnouf M. P., Hemker P. W., Swart A. C., Macfarlane R. G. Formation of prothrombin converting activity. Nature. 1967 Jul 15;215(5098):248–251. doi: 10.1038/215248a0. [DOI] [PubMed] [Google Scholar]
  42. Hirsh J., Castelan D. J., Loder P. B. Spontaneous bruising associated with a defect in the interaction of platelets with connective tissue. Lancet. 1967 Jul 1;2(7505):18–21. doi: 10.1016/s0140-6736(67)90059-1. [DOI] [PubMed] [Google Scholar]
  43. Hirsh J., McBride J. A. Increased platelet adhesiveness in recurrent venous thrombosis and pulmonary embolism. Br Med J. 1965 Oct 2;2(5465):797–799. doi: 10.1136/bmj.2.5465.797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Horowitz H. I., Cohen B. D., Martinez P., Papayoanou M. F. Defective ADP-induced platelet factor 3 activation in uremia. Blood. 1967 Sep;30(3):331–340. [PubMed] [Google Scholar]
  45. KASHIWAGI H., RIDDLE J. M., ABRAHAM J. P., FRAME B. FUNCTIONAL AND ULTRASTRUCTURAL ABNORMALITIES OF PLATELETS IN EHLERS-DANLOS SYNDROME. Ann Intern Med. 1965 Aug;63:249–254. doi: 10.7326/0003-4819-63-2-249. [DOI] [PubMed] [Google Scholar]
  46. KISSMEYER-NIELSEN F., MADSEN C. B. Platelets in blood stored in untreated and siliconed glass bottles and plastic bags. II. Survival studies. J Clin Pathol. 1961 Nov;14:630–636. doi: 10.1136/jcp.14.6.630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. LEEKSMA C. H., COHEN J. A. Determination of the life of human blood platelets using labelled diisopropylfluorophosphanate. Nature. 1955 Mar 26;175(4456):552–553. doi: 10.1038/175552b0. [DOI] [PubMed] [Google Scholar]
  48. MCDONALD L., BRAY C., FIELD C., LOVE F., DAVIES B. HOMOCYSTINURIA, THROMBOSIS, AND THE BLOOD-PLATELETS. Lancet. 1964 Apr 4;1(7336):745–746. doi: 10.1016/s0140-6736(64)92852-1. [DOI] [PubMed] [Google Scholar]
  49. MURPHY E. A., MUSTARD J. F. Dicumarol therapy and platelet turnover. Circ Res. 1961 Mar;9:402–406. doi: 10.1161/01.res.9.2.402. [DOI] [PubMed] [Google Scholar]
  50. McDONALD L. Coagulability of the blood in ischaemic heart-disease. Lancet. 1957 Sep 7;273(6993):457–460. doi: 10.1016/s0140-6736(57)90768-7. [DOI] [PubMed] [Google Scholar]
  51. McNicol G. P., Douglas A. S. Platelet abnormality in human scurvy. Lancet. 1967 May 6;1(7497):975–978. [PubMed] [Google Scholar]
  52. Murphy E. A., Robinson G. A., Rowsell H. C., Mustard J. F. The pattern of platelet disappearance. Blood. 1967 Jul;30(1):26–38. [PubMed] [Google Scholar]
  53. Murphy S., Gardner F. H. Effect of storage temperature on maintenance of platelet viability--deleterious effect of refrigerated storage. N Engl J Med. 1969 May 15;280(20):1094–1098. doi: 10.1056/NEJM196905152802004. [DOI] [PubMed] [Google Scholar]
  54. Mustard J. F., Glynn M. F., Nishizawa E. E., Packham M. A. Platelet-surface interactions: relationship to thrombosis and hemostasis. Fed Proc. 1967 Jan-Feb;26(1):106–114. [PubMed] [Google Scholar]
  55. Mustard J. F. Hemostasis and thrombosis. Semin Hematol. 1968 Apr;5(2):91–106. [PubMed] [Google Scholar]
  56. Mustard J. F., Jorgensen L., Hovig T., Glynn M. F., Rowsell H. C. Rôle of platelets in thrombosis. Thromb Diath Haemorrh Suppl. 1966;21:131–158. [PubMed] [Google Scholar]
  57. Niewiarowski S., Bańkowski E., Rogowicka I. Studies on the adsorption and activation of the Hageman factor (factor XII) by collagen and elastin. Thromb Diath Haemorrh. 1965 Nov 15;14(3-4):387–400. [PubMed] [Google Scholar]
  58. Packham M. A., Nishizawa E. E., Mustard J. F. Response of platelets to tissue injury. Biochem Pharmacol. 1968 Mar;(Suppl):171–184. doi: 10.1016/0006-2952(68)90304-3. [DOI] [PubMed] [Google Scholar]
  59. Packham M. A., Warrior E. S., Glynn M. F., Senyi A. S., Mustard J. F. Alteration of the response of platelets to surface stimuli by pyrazole compounds. J Exp Med. 1967 Jul 1;126(1):171–188. doi: 10.1084/jem.126.1.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Pease D. C. Polysaccharides associated with the exterior surface of epithelial cells: kidney, intestine, brain. J Ultrastruct Res. 1966 Aug;15(5):555–588. doi: 10.1016/s0022-5320(66)80128-4. [DOI] [PubMed] [Google Scholar]
  61. Phillis J. W., York D. H. Pharmacological studies on a cholinergic inhibition in the cerebral cortex. Brain Res. 1968 Sep;10(3):297–306. doi: 10.1016/0006-8993(68)90201-1. [DOI] [PubMed] [Google Scholar]
  62. Quick A. J. Salicylates and bleeding: the aspirin tolerance test. Am J Med Sci. 1966 Sep;252(3):265–269. doi: 10.1097/00000441-196609000-00003. [DOI] [PubMed] [Google Scholar]
  63. ROBERTSON J. D. The molecular structure and contact relationships of cell membranes. Prog Biophys Mol Biol. 1960;10:343–418. [PubMed] [Google Scholar]
  64. Rabiner S. F., Hrodek O. Platelet factor 3 in normal subjects and patients with renal failure. J Clin Invest. 1968 Apr;47(4):901–912. doi: 10.1172/JCI105782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. SALZMAN E. W. MEASUREMENT OF PLATELET ADHESIVENESS. A SIMPLE IN VITRO TECHNIQUE DEMONSTRATING AN ABNORMALITY IN VON WILLEBRAND'S DISEASE. J Lab Clin Med. 1963 Nov;62:724–735. [PubMed] [Google Scholar]
  66. SPAET T. H., ZUCKER M. B. MECHANISM OF PLATELET PLUG FORMATION AND ROLE OF ADENOSINE DIPHOSPHATE. Am J Physiol. 1964 Jun;206:1267–1274. doi: 10.1152/ajplegacy.1964.206.6.1267. [DOI] [PubMed] [Google Scholar]
  67. Spaet T. H., Lejnieks I. Studies on the mechanism whereby platelets are clumped by adenosine diphosphate. Thromb Diath Haemorrh. 1966 Jan 31;15(1):36–51. [PubMed] [Google Scholar]
  68. Stefanini M., Karaca M. Acquired thrombocytopathy in patients with pernicious anaemia. Reversion of biochemical abnormalities after treatment with vitamin B 12. Lancet. 1966 Feb 19;1(7434):400–402. doi: 10.1016/s0140-6736(66)91394-8. [DOI] [PubMed] [Google Scholar]
  69. Stewart J. H., Castaldi P. A. Uraemic bleeding: a reversible platelet defect corrected by dialysis. Q J Med. 1967 Jul;36(143):409–423. [PubMed] [Google Scholar]
  70. Sullivan J. M., Harken D. E., Gorlin R. Pharmacologic control of thromboembolic complications of cardiac-valve replacement. A preliminary report. N Engl J Med. 1968 Sep 12;279(11):576–580. doi: 10.1056/NEJM196809122791104. [DOI] [PubMed] [Google Scholar]
  71. WEISS H. J., EICHELBERGER J. W., Jr SECONDARY THROMBOCYTOPATHIA. PLATELET FACTOR 3 IN VARIOUS DISEASE STATES. Arch Intern Med. 1963 Dec;112:827–834. doi: 10.1001/archinte.1963.03860060065005. [DOI] [PubMed] [Google Scholar]
  72. Wijnja L., Snijder J. A., Nieweg H. O. Acetylsalicylic acid as a cause of pancytopenia from bone-marrow damage. Lancet. 1966 Oct 8;2(7467):768–770. doi: 10.1016/s0140-6736(66)90363-1. [DOI] [PubMed] [Google Scholar]
  73. Wright H. P., Thompson R. H., Zilkha K. J. Platelet adhesiveness in multiple sclerosis. Lancet. 1965 Nov 27;2(7422):1109–1110. doi: 10.1016/s0140-6736(65)90069-3. [DOI] [PubMed] [Google Scholar]
  74. YAMADA E. The fine structure of the megakaryocyte in the mouse spleen. Acta Anat (Basel) 1957;29(3):267–290. doi: 10.1159/000141169. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES